UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Haemonetics
HAE
$3.89B
| $5.56M | ﹤0.01% |
62,024
-4,852
| -7% | -$433K |
|
|
APLS
1127
DELISTED
Apellis Pharmaceuticals
APLS
| $5.55M | ﹤0.01% |
145,946
+46,142
| +46% | +$2.03M |
|
1128
ESAB
ESAB
$5.38B
| $5.54M | ﹤0.01% |
78,910
-1,137
| -1% | -$79.1K |
|
1129
Newell Brands
NWL
$2.38B
| $5.53M | ﹤0.01% |
611,866
-963,468
| -61% | -$9.59M |
|
1130
10x Genomics
TXG
$6B
| $5.52M | ﹤0.01% |
133,741
-300
| -0.2% | -$15.6K |
|
1131
Qiagen
QGEN
$8.54B
| $5.51M | ﹤0.01% |
128,378
-6,105
| -5% | -$285K |
|
1132
Workiva
WK
$3.36B
| $5.5M | ﹤0.01% |
54,266
+3,286
| +6% | +$342K |
|
1133
Concentrix
CNXC
$1.5B
| $5.48M | ﹤0.01% |
68,462
-8,340
| -11% | -$654K |
|
1134
Xencor
XNCR
$1.5B
| $5.48M | ﹤0.01% |
272,053
+4,190
| +2% | +$95.3K |
|
|
TMHC
1135
DELISTED
Taylor Morrison
TMHC
| $5.47M | ﹤0.01% |
128,282
+30
| +0% | +$1.41K |
|
|
TXNM
1136
TXNM Energy Inc
TXNM
$6.41B
| $5.45M | ﹤0.01% |
122,143
+9,690
| +9% | +$433K |
|
1137
Meritage Homes
MTH
$4.58B
| $5.42M | ﹤0.01% |
88,610
+3,834
| +5% | +$264K |
|
1138
Insight Enterprises
NSIT
$3.89B
| $5.4M | ﹤0.01% |
37,082
-4,320
| -10% | -$644K |
|
|
HPP
1139
Hudson Pacific Properties
HPP
$747M
| $5.35M | ﹤0.01% |
114,846
-3,251
| -3% | -$140K |
|
|
PINC
1140
DELISTED
Premier
PINC
| $5.34M | ﹤0.01% |
248,443
-4,455
| -2% | -$111K |
|
1141
First Bancorp
FBNC
$2.6B
| $5.33M | ﹤0.01% |
189,454
-139,310
| -42% | -$4.27M |
|
1142
Viking Therapeutics
VKTX
$3.7B
| $5.3M | ﹤0.01% |
+478,695
| New | +$6.85M |
|
1143
Maximus
MMS
$3.17B
| $5.28M | ﹤0.01% |
70,703
+5,652
| +9% | +$460K |
|
|
ETRN
1144
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $5.27M | ﹤0.01% |
562,822
-32,251
| -5% | -$308K |
|
1145
Lumentum
LITE
$55.5B
| $5.26M | ﹤0.01% |
116,379
+5,042
| +5% | +$256K |
|
1146
Southwest Gas
SWX
$6.47B
| $5.24M | ﹤0.01% |
86,777
+3,554
| +4% | +$227K |
|
1147
KB Home
KBH
$3.37B
| $5.23M | ﹤0.01% |
113,055
+2,106
| +2% | +$107K |
|
1148
TriNet
TNET
$3.02B
| $5.16M | ﹤0.01% |
44,283
+10,310
| +30% | +$1.09M |
|
|
BECN
1149
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $5.14M | ﹤0.01% |
66,633
-7,629
| -10% | -$616K |
|
1150
NeoGenomics
NEO
$1.96B
| $5.14M | ﹤0.01% |
417,486
+22,021
| +6% | +$327K |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.